Medicus Pharma highlights positive dose-response in updated skin cancer trial results
Medicus Pharma (NASDAQ:MDCX) has reported additional results from a pre-specified expanded dataset a…
proactiveinvestors.com

No data available
No analyst coverage available for this stock.
Medicus Pharma (NASDAQ:MDCX) has reported additional results from a pre-specified expanded dataset a…

No company information available